Award
Delivery Order #SPE2DR26FDET3
Short-Term Delivery Order for Nucala Auto-Injectors to Support Health Initiatives
Buyer
Defense Logistics Agency
Award Amount
$3,863.68
Ceiling
$3,863.68
Awarded
March 03, 2026
Period of Performance
Mar 03, 2026 – Mar 04, 2026
Identifier
SPE2DR26FDET3
NAICS
424210
This award represents a delivery order contract, a subset of the parent definitive contract held by DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical distribution and related services. The contract procures Nucala 100 MG/ML auto-injectors, essential pharmaceutical products for government health programs. Awarded for a brief performance period, this short-term order ensures timely supply and supports ongoing healthcare needs. The contract is part of a broader health sector initiative to streamline medication procurement. This specific delivery order is competitively managed under the existing contract vehicle, reinforcing DMS Pharmaceutical Group's critical role in government pharmaceutical supply chains. The performance period is concise, enabling rapid response to health demand requirements.
Description
4571018817!NUCALA 100 MG/ML AUTO-INJECTORML